ESTRIMA SPA (ESTM.MI) Fundamental Analysis & Valuation

BIT:ESTM • IT0005468191

Current stock price

0.0994 EUR
+0 (+0.4%)
Last:

This ESTM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ESTM.MI Profitability Analysis

1.1 Basic Checks

  • In the past year ESTM has reported negative net income.
  • In the past year ESTM had a positive cash flow from operations.
  • ESTM had negative earnings in each of the past 5 years.
  • In the past 5 years ESTM reported 4 times negative operating cash flow.
ESTM.MI Yearly Net Income VS EBIT VS OCF VS FCFESTM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

  • ESTM's Return On Assets of -9.93% is on the low side compared to the rest of the industry. ESTM is outperformed by 93.33% of its industry peers.
  • ESTM has a Return On Equity of -41.27%. This is in the lower half of the industry: ESTM underperforms 76.67% of its industry peers.
Industry RankSector Rank
ROA -9.93%
ROE -41.27%
ROIC N/A
ROA(3y)-17.96%
ROA(5y)N/A
ROE(3y)-73.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESTM.MI Yearly ROA, ROE, ROICESTM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • The Gross Margin of ESTM (20.96%) is better than 73.33% of its industry peers.
  • ESTM's Gross Margin has improved in the last couple of years.
  • ESTM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.33%
GM growth 5Y4.17%
ESTM.MI Yearly Profit, Operating, Gross MarginsESTM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ESTM.MI Health Analysis

2.1 Basic Checks

  • ESTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ESTM remains at a similar level compared to 1 year ago.
  • ESTM has about the same amout of shares outstanding than it did 5 years ago.
  • ESTM has a worse debt/assets ratio than last year.
ESTM.MI Yearly Shares OutstandingESTM.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2021 2022 2023 2024 5M 10M
ESTM.MI Yearly Total Debt VS Total AssetsESTM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of 0.45, we must say that ESTM is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ESTM (0.45) is worse than 80.00% of its industry peers.
  • ESTM has a debt to FCF ratio of 3.90. This is a good value and a sign of high solvency as ESTM would need 3.90 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.90, ESTM belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • A Debt/Equity ratio of 0.97 indicates that ESTM is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.97, ESTM is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 3.9
Altman-Z 0.45
ROIC/WACCN/A
WACC6.68%
ESTM.MI Yearly LT Debt VS Equity VS FCFESTM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • ESTM has a Current Ratio of 1.26. This is a normal value and indicates that ESTM is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.26, ESTM is doing good in the industry, outperforming 63.33% of the companies in the same industry.
  • ESTM has a Quick Ratio of 1.26. This is a bad value and indicates that ESTM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ESTM's Quick ratio of 0.77 is on the low side compared to the rest of the industry. ESTM is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.77
ESTM.MI Yearly Current Assets VS Current LiabilitesESTM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ESTM.MI Growth Analysis

3.1 Past

  • ESTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.03%, which is quite impressive.
  • Looking at the last year, ESTM shows a very negative growth in Revenue. The Revenue has decreased by -22.99% in the last year.
  • Measured over the past years, ESTM shows a very strong growth in Revenue. The Revenue has been growing by 40.21% on average per year.
EPS 1Y (TTM)82.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.34%
Revenue 1Y (TTM)-22.99%
Revenue growth 3Y54.95%
Revenue growth 5Y40.21%
Sales Q2Q%-33.9%

3.2 Future

  • ESTM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.96% yearly.
  • ESTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.69% yearly.
EPS Next Y40%
EPS Next 2Y22.47%
EPS Next 3Y16.96%
EPS Next 5YN/A
Revenue Next Year-33.16%
Revenue Next 2Y-15.37%
Revenue Next 3Y-6.01%
Revenue Next 5Y3.69%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ESTM.MI Yearly Revenue VS EstimatesESTM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
ESTM.MI Yearly EPS VS EstimatesESTM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

Find the best growth stocksShow best growing peers

2

4. ESTM.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • ESTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ESTM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESTM.MI Price Earnings VS Forward Price EarningsESTM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ESTM is valued a bit more expensive than 66.67% of the companies in the same industry.
  • ESTM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ESTM is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.67
EV/EBITDA 15.36
ESTM.MI Per share dataESTM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ESTM's earnings are expected to grow with 16.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.47%
EPS Next 3Y16.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ESTM.MI Dividend Analysis

5.1 Amount

  • No dividends for ESTM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ESTM.MI Fundamentals: All Metrics, Ratios and Statistics

ESTRIMA SPA

BIT:ESTM (3/30/2026, 7:00:00 PM)

0.0994

+0 (+0.4%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners3.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.96M
Revenue(TTM)33.33M
Net Income(TTM)-2.14M
Analysts37.78
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-0.03%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF 1.67
P/OCF 1.33
P/B 0.57
P/tB 0.65
EV/EBITDA 15.36
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.06
FCFY59.97%
OCF(TTM)0.07
OCFY75.21%
SpS1.12
BVpS0.17
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.93%
ROE -41.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.96%
FCFM 5.32%
ROA(3y)-17.96%
ROA(5y)N/A
ROE(3y)-73.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.33%
GM growth 5Y4.17%
F-Score5
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 3.9
Debt/EBITDA 14.53
Cap/Depr 34.03%
Cap/Sales 1.35%
Interest Coverage N/A
Cash Conversion 639.13%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 0.77
Altman-Z 0.45
F-Score5
WACC6.68%
ROIC/WACCN/A
Cap/Depr(3y)101.11%
Cap/Depr(5y)147.83%
Cap/Sales(3y)4.41%
Cap/Sales(5y)7.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.34%
EPS Next Y40%
EPS Next 2Y22.47%
EPS Next 3Y16.96%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.99%
Revenue growth 3Y54.95%
Revenue growth 5Y40.21%
Sales Q2Q%-33.9%
Revenue Next Year-33.16%
Revenue Next 2Y-15.37%
Revenue Next 3Y-6.01%
Revenue Next 5Y3.69%
EBIT growth 1Y72.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3Y27.29%
EBIT Next 5YN/A
FCF growth 1Y143.87%
FCF growth 3YN/A
FCF growth 5Y22.2%
OCF growth 1Y215.13%
OCF growth 3YN/A
OCF growth 5Y21.22%

ESTRIMA SPA / ESTM.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ESTRIMA SPA?

ChartMill assigns a fundamental rating of 2 / 10 to ESTM.MI.


What is the valuation status of ESTRIMA SPA (ESTM.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to ESTRIMA SPA (ESTM.MI). This can be considered as Overvalued.


How profitable is ESTRIMA SPA (ESTM.MI) stock?

ESTRIMA SPA (ESTM.MI) has a profitability rating of 1 / 10.


What is the financial health of ESTRIMA SPA (ESTM.MI) stock?

The financial health rating of ESTRIMA SPA (ESTM.MI) is 3 / 10.


What is the expected EPS growth for ESTRIMA SPA (ESTM.MI) stock?

The Earnings per Share (EPS) of ESTRIMA SPA (ESTM.MI) is expected to grow by 40% in the next year.